lung%20cancer
LUNG CANCER
Lung cancer is having a malignant tumor in the lungs especially in the cells lining air passages.
Primary tumor-related signs and symptoms are cough, dyspnea, hemoptysis, and chest discomfort.
Signs and symptoms due to intrathoracic spread may involve the nerves (hoarseness, dyspnea, muscle wasting of upper limb, Horner's syndrome), chest wall and pleura (chest pain, dyspnea) and vascular structures (facial swelling, dilated neck veins, cardiac tamponade) & viscera (dsyphagia).
The signs and symptoms due to metastatic spread are bone pain with or without pleuritic pain, neurologic symptoms, limb weakness, unsteady gait, cervical lymphadenopathy, and skin nodules.

Surgical Intervention

Surgery for Non-Small Cell Lung Cancer (NSCLC)
  • Resectability of tumor should be fully assessed
  • May offer the best chance of survival & possible cure in non-small cell lung cancer (NSCLC) patients with Stage I-II disease
    • May be considered in patients with N2 disease responsive to induction chemotherapy
  • Surgery is recommended for patients with the following:
    • ≥8 mm solid nodule on LDCT screening that has high probability of cancer as shown on PET/CT scan
    • ≥8 mm solid nodule that increased in size in chest CT &/or PET/CT scan with high probability for cancer
    • ≥15 mm solid nodule with the same measurements in LDCT after 6 months or in PET/CT scan with high probability for cancer
    • ≥6 mm part solid nodule with ≥8 mm solid component in follow-up LDCT with high probability for cancer in PET/CT scan
    • New or growing part solid nodule with ≥4 mm solid component in LDCT with high probability for cancer in chest CT scan with or without contrast &/or PET/CT scan
    • New or growing NS nodule ≥20 mm in size during follow-up or annual LDCT
  • Treatment of choice for stage I & II non-small cell lung cancer (NSCLC)
    • In the absence of medical contraindications to surgery, complete resection (ie lobectomy) with clear surgical margins should be achieved as much as possible
    • In patients with comorbidities who are not able to tolerate lobectomy, sublobar resection is recommended
    • Nodal dissection is preferred over simple intraoperative sampling for mediastinal lymph node
    • Sleeve lobectomy is recommended for total resection of centrally or locally advanced non-small cell lung cancer (NSCLC)
    • Segmental or wedge resection is recommended for patients with impaired pulmonary function
  • Surgery in stage IIIA N2 lung cancer is controversial
    • Surgery is considered in resectable stage IIIA N0-1 tumors, followed by adjuvant chemotherapy
    • Usually not recommended if with involvement of N2; patient may undergo chemotherapy prior to surgery to decrease the tumor size, eliminate micrometastases & to improve patient’s tolerance to procedure
  • Video-assisted thoracic surgery (VATS) is a less invasive & reasonable approach for patients with no anatomic or surgical contraindication
  • For highly selected patients with recurrent NSCLC, stereotactic radiation surgery & surgical resection of isolated cerebral metastasis are recommended
 
Surgery for Small Cell Lung Cancer (SCLC)
  •  Considered only for patients with clinical stage I & in LD patients with sufficient pulmonary function & no evidence of metastases to mediastinal or supraclavicular lymph nodes
    • Patients with clinical stage in excess of T1-2, N0 do not benefit from surgery
  • Lobectomy or pneumonectomy should be done followed by detailed dissection of the mediastinal lymph nodes
  • Platinum-based adjuvant chemotherapy is recommended after complete resection
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 02 Mar 2017
The placement of personalized inhaler technique reminder labels on dry-powder asthma inhalers may improve the retention of inhaler technique skills after training and potentially extend the benefit of the training onto asthma outcomes, according to a study.
Audrey Abella, 08 Feb 2018
Better clinical efficacy was observed among cancer patients with postoperative hospital-acquired pneumonia (HAP) who received prolonged infusion of the mixed preparation of the broad-spectrum β-lactamase inhibitor tazobactam and β-lactam antibiotic piperacillin (TZP) compared with those who received the traditional regimen, according to a study.

Stephen Padilla, 02 Mar 2017
Use of vitamin D supplementation prevents acute respiratory tract infection, with individuals who are very deficient in vitamin D and those not receiving additional bolus doses benefitting the most, a recent study has found.
18 Feb 2018
Plasma brain natriuretic peptide (BNP) threshold of 340 pg/mL appears to strongly predict survival up to 5 years in patients with pulmonary arterial hypertension, a study suggests.